A detailed history of Caldwell Sutter Capital, Inc. transactions in Psychemedics Corp stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 250 shares of PMD stock, worth $585. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$585
Previous $605,000 4.46%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$2.25 - $2.88 $495 - $633
220 Added 733.33%
250 $605,000
Q3 2023

Oct 25, 2023

SELL
$3.66 - $5.05 $2,002 - $2,762
-547 Reduced 94.8%
30 $119,000
Q2 2023

Jul 19, 2023

BUY
$4.55 - $5.6 $2,625 - $3,231
577 New
577 $2.63 Million

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $13.2M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Caldwell Sutter Capital, Inc. Portfolio

Follow Caldwell Sutter Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Sutter Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Sutter Capital, Inc. with notifications on news.